1985
DOI: 10.1016/s0196-0644(85)81080-5
|View full text |Cite
|
Sign up to set email alerts
|

Fatal ventricular fibrillation following verapamil in Wolff-Parkinson-White syndrome with atrial fibrillation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
1
1

Year Published

1991
1991
2014
2014

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(7 citation statements)
references
References 6 publications
0
5
1
1
Order By: Relevance
“…2). Jacob et al previously reported the case of a young patient presenting with intermittently preexcited AF who subsequently experienced fatal VF after receiving verapamil 5 . However, this case differs from ours in that he was maximally preexcited, and his heart rate was markedly faster (250 bpm vs 120 bpm), prior to the development of VF.…”
Section: Discussioncontrasting
confidence: 50%
See 1 more Smart Citation
“…2). Jacob et al previously reported the case of a young patient presenting with intermittently preexcited AF who subsequently experienced fatal VF after receiving verapamil 5 . However, this case differs from ours in that he was maximally preexcited, and his heart rate was markedly faster (250 bpm vs 120 bpm), prior to the development of VF.…”
Section: Discussioncontrasting
confidence: 50%
“…Second, there are no published case reports, to our knowledge, of diltiazem or metoprolol precipitating VF in a WPW patient presenting with AF. Adenosine and verapamil, whose negative dromotropic effects are more potent than that of diltiazem and possibly even metoprolol, should not be used in such a setting 2,3,5,6,7,8 . One explanation proposed by Gulamhusein et al for the acceleration of preexcited AF by verapamil relates to its direct vasodilator effect, resulting in hypotension and reflex sympathetic activity that can potentially accelerate antegrade AP conduction and induce VF 8 .…”
Section: Discussionmentioning
confidence: 99%
“…These nondihydropyridine calcium channel blockers should not be used in patients with LV systolic dysfunction and decompensated HF owing to their negative inotropic effects, but they may be used in patients with HF with preserved LV systolic function. In addition, these agents should not be used in patients with pre-excitation and AF due to the potential for shortening bypass tract refractoriness which may accelerate the ventricular rate to precipitate hypotension or ventricular fibrillation (281, 289) (Section 7.8).…”
Section: 1 Specific Pharmacological Agents For Rate Controlmentioning
confidence: 99%
“…This is in marked contrast to the effects of intravenous verapamil given under these circumstances, the administration of which frequently results in hemodynamic deterioration and occasionally in death. 31 In addition, the current study has demonstrated that, despite shortening of accessory connection refractoriness by adenosine, the risks associated with inadvertent administration during preexcited atrial flutter are small and should not discourage the use of adenosine as a diagnostic agent in broad complex regular tachycardias of uncertain origin. Although not observed in this study, it is possible that conversion of atrial flutter to sustained atrial fibrillation may occur, and it should be emphasized that, as with administration of all antiarrhythmic agents, continuous electrocardiographic monitoring and availability of DC cardioversion is a necessary precaution during administration of adenosine.…”
Section: Discussionmentioning
confidence: 99%